Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2016-05-17 to 2017-11-06
ROUNDS
2
led 1, joined 1
LED ROUNDS · USD
$6.8M
across 1 round · 1 co-led, split evenly
CO-INVESTORS
3
most often with Versant Ventures
Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2016-05-17 to 2017-11-06
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Nouscom A clinical-stage, cancer interception focused biotech developing next-generation immunotherapies | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $48.7M | 2017-11-06 | [ PART ] |
Nouscom A clinical-stage, cancer interception focused biotech developing next-generation immunotherapies | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $13.6M | 2016-05-17 | [ LEAD ] |